Evidence map›Paper›PMID 32602279›Full record

ReviewDementia and neurocognitive disorders2020

Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association.

Kee Hyung Park, Jae Sung Lim, Sang Won Seo, Yong Jeong, Young Noh, Seong Ho Koh, Jae Sung Bae, Sun Ah Park, Soh Jeong Yang, Hee Jin Kim and 4 more

Abstract readReview
In one paragraph

Review in Dementia and neurocognitive disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kee Hyung ParkDepartment of Neurology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea. khpark@gachon.ac.kr.ORCID https://orcid.org/0000-0001-6847-6679
Jae Sung LimDepartment of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute, Hallym University College of Medicine, Anyang, Korea.ORCID https://orcid.org/0000-0001-6157-2908
Sang Won SeoDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2568-0797
Yong JeongDepartment of Bio and Brain Engineering, KAIST, Daejeon, Korea.ORCID https://orcid.org/0000-0002-5907-3787
Young NohDepartment of Neurology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.ORCID https://orcid.org/0000-0002-9633-3314
Seong Ho KohDepartment of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.ORCID https://orcid.org/0000-0001-5419-5761
Jae Sung BaeDepartment of Physiology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Korea.ORCID https://orcid.org/0000-0002-8270-0072
Sun Ah ParkLab for Neurodegenerative Dementia, Department of Anatomy and Department of Neurology, Ajou University School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-3027-3259
Soh Jeong YangDepartment of Neurology, Yonsei University Health System, Seoul, Korea.ORCID https://orcid.org/0000-0001-7033-694X
Hee Jin KimDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-3186-9441
Juhee ChinDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-3784-9716
Jee Hoon RohDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-3243-0529
Seong Soo A AnDepartment of Bionano Technology, Gachon University, Seongnam, Korea.ORCID https://orcid.org/0000-0002-8123-6183
Academic Committee of the Korean Dementia Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of repeated failures of clinical trials, the concept of Alzheimer's disease (AD) has been changing rapidly in recent years. As suggested by the National Institute on Aging and the Alzheimer's Association Research Framework, the diagnosis and classification of AD is now based on biomarkers rather than on symptoms, allowing more accurate identification of proper candidates for clinical trials by pathogenesis and disease stage. Recent development in neuroimaging has provided a way to reveal the complex dynamics of amyloid and tau in the brain

Indexed as

Alzheimer DiseaseBiomarkersGenetic ResearchNeuroinflammationNeuropsychologyTranslational Medical Research

Identifiers

PMID32602279
PMCPMC7326615

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.